Analysis: Sotac Pharmaceuticals Ltd.

NSE:SOTAC Pharmaceuticals Bulk Drugs & Formulation Market cap: ₹100 cr

Research report

companyname: Sotac Pharmaceuticals Limited ticker: SOTAC sector: Pharmaceuticals Sotac Pharmaceuticals Limited is a contract manufacturer of pharmaceutical formulations. Incorporated on December 18, 2015, it makes tablets, capsules, oral liquids, dry syrups, and external preparations such as ointments, lotions, and creams. The business model is straightforward: pharmaceutical marketers bring their brands and product specifications, and Sotac manufactures those products at its plants on a contra...

Read the full report →
RS rating: 15 Stage: Stage 4

Get valuation models, detailed research reports, thematic primers, one-pagers, risk analysis, growth triggers, bear case, capex tracker, walk the talk, and more for Sotac Pharmaceuticals Ltd. and 4,900+ companies.

Sign in
5-day free pass. No card required.